Type 2 diebetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes mellitus Age 30 to 70 years
Exclusion criteria
Exclusion criteria: Insulin or liraglutide injection People under 30 and over 70 Chronic cardiovascular disease, major depression, chronic liver and kidney disease, chronic thyroid disorders and malignancies including cancer Neuroleptics, medical Herbs or herbs to control blood sugar over the past 6 months Patients being treated with a special diet such as vegetarian diets or a specific exercise program. People with food or seasonal allergies Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;Low-density lipoprotein. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;High-density lipoprotein. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;Triglyceride. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;HbA1c. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Chromatography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences